Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29)

Key Points

• The analysis reveals specific ligand-binding sites on the integrin α4β1.
• Identification of these sites might enhance therapeutic targeting strategies.
• Approach includes computational modeling and structural biology techniques.
• Understanding these binding sites may enable the development of new treatments for related diseases.